Annual Report

Overview

The report presents NATCO Pharma's FY22 resilience through consolidated revenue of ₹20,438 million despite pandemic-related pressures. It introduces the company's first voluntary Business Responsibility & Sustainability Report, covering environmental, social and governance disclosures. The report also highlights renewable-energy and resource-conservation initiatives across operations. Community programs remained significant, with ₹121.20 million spent on CSR activities during the year.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2021-2022
Period: 1 April 2021 – 31 March 2022
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services